HTMC0658 tablets

HTMC0658 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HTMC0658 tablets, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps [Phase 2]

See pricing